Fox News: Pay for Delay: U.S. Says Drugmakers Block Cheaper Generic Rivals
The Federal Trade Commission has found an "unprecedented" 60 percent 
jump in drug industry "pay for delay" deals that stall consumers' 
access to cheaper generic drugs, hurting consumers' and taxpayers' 
wallets. The report could lay the groundwork for even more antitrust, 
anti-monopoly actions the government has increasingly been bringing 
against Big Pharma. Drug companies "struck an unprecedented number of 
deals" in fiscal 2010, where drug makers of brand name 
pharmaceuticals paid "potential generic rivals and generic companies 
to defer the introduction of lower-cost medicines for American 
consumers," the FTC said in a statement (MacDonald, 5/4).

http://www.kaiserhealthnews.org/Daily-Reports/2011/May/05/generic-drugs.aspx

(Medicare had dropped several inexpensive generics that I use from 
the Part D formulary.  So yes they are now $4 or $10 and they are now 
completely out-of-pocket.  Sylvia)



Powered by LSoft's LISTSERV(R) list management software